{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "favipiravir",
      "treatment",
      "viral load"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33518623",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "29"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.7883/yoken.JJID.2020.827"
    ],
    "Journal": {
      "ISSN": "1884-2836",
      "JournalIssue": {
        "Volume": "74",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep",
          "Day": "22"
        }
      },
      "Title": "Japanese journal of infectious diseases",
      "ISOAbbreviation": "Jpn J Infect Dis"
    },
    "ArticleTitle": "Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir.",
    "Pagination": {
      "StartPage": "416",
      "EndPage": "420",
      "MedlinePgn": "416-420"
    },
    "Abstract": {
      "AbstractText": [
        "We retrospectively studied nasopharyngeal severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) viral load in coronavirus disease 2019 (COVID-19) patients who were hospitalized between January 13 and April 1, 2020. Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) was conducted using primers and probes targeting the ORF1ab and N genes. All patients were classified in the following groups: Group 1: received favipiravir + chloroquine or hydroxychloroquine + lopinavir/ritonavir or darunavir/ritonavir for 5-10 days, Group 2: received chloroquine or hydroxychloroquine + lopinavir/ritonavir or darunavir/ritonavir for 5-10 days, and Group 3: no antiviral medication. Among the 115 patients, 38 (33%), 54 (47%), and 23 (20%) were in Groups 1, 2, and 3, respectively. The median (IQR) baseline viral loads on day 0 of Groups 1, 2, and 3 were 7.2 (6.0-8.1), 6.9 (5.8-7.8), and 6.9 (5.8-7.6) log<sub>10</sub> copies/mL, respectively. The reductions of mean viral loads on day 3 from baseline were 2.41, 1.38, and 2.19 log<sub>10</sub> copies/mL in the corresponding groups (P < 0.05). There were no differences in the reduction of mean viral loads from baseline among the three groups on days 5 and 10 (P > 0.05). Multiple logistic regression analysis showed that receiving favipiravir was associated with nasopharyngeal viral load reduction at three days (P = 0.001). Significant nasopharyngeal SARS-CoV-2 viral load reduction was achieved in COVID-19 patients who received a favipiravir-containing regimen."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Manosuthi",
        "ForeName": "Weerawat",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Sciences, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Jeungsmarn",
        "ForeName": "Somlerk",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Sciences, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Okada",
        "ForeName": "Pilailuk",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Suwanvattana",
        "ForeName": "Pawita",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Sciences, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Wongboot",
        "ForeName": "Warawan",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Thawornwan",
        "ForeName": "Unchana",
        "Initials": "U"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Charoenpong",
        "ForeName": "Lantharita",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Wiboonchutikul",
        "ForeName": "Surasak",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Uttayamakul",
        "ForeName": "Sumonmal",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Pongpirul",
        "ForeName": "Wannarat A",
        "Initials": "WA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Wachirapan",
        "ForeName": "Apichat",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Office of the Permanent Secretary, Ministry of Public Health, Thailand."
          }
        ],
        "LastName": "Warachit",
        "ForeName": "Paijit",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Japan",
    "MedlineTA": "Jpn J Infect Dis",
    "NlmUniqueID": "100893704",
    "ISSNLinking": "1344-6304"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Amides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Pyrazines"
    },
    {
      "RegistryNumber": "EW5GL2X7E0",
      "NameOfSubstance": "favipiravir"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Amides"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Therapy, Combination"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospitalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nasopharynx"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Pyrazines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [
        "drug effects",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Viral Load"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}